Skip to main content
This website uses cookies. By continuing to use this website you are agreeing to our use of cookies as described in our privacy policy.
Client Work

Novartis AG and Novartis Pharmaceuticals Canada Inc. v. RhoxalPharma Inc. and the Minister of Health

Fasken
Reading Time 1 minute read Subscribe
Proceedings to prohibit the Minister of Health from issuing a notice of compliance which would allow the sale, by RhoxalPharma, of a generic version of cyclosporine, a drug used to prevent transplant rejection. The patent at issue covered a pharmaceutical formulation containing cyclosporine in the form of a hydrosol. The application was eventually dismissed. RhoxalPharma was advised in these proceedings by a team from Fasken Martineau that included Marie Lafleur and Martin Sheehan. For more information, see (2004) FC 474 and (2005) FCA 11.

    Subscribe

    Receive email updates from our team

    Subscribe